Hosted on MSN11mon
FDA’s Marks says global dialogue on gene therapy regulation key for patient accessaccording to the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research director Peter Marks. Marks was speaking at a panel discussion on the regulatory landscape ...
At the recent CBER agency workshop on cell therapies and tissue-based products, a few surprising ideas discussed could have ...
Hosted on MSN5mon
FDA approves first self-administered flu vaccine sprayflexibility and accessibility," Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said in a statement. The FluMist vaccine, manufactured by AstraZeneca ...
So to help explain these changes, I've asked Dr. Peter Marks. He's the director for the Center for Biologics Evaluation and Research at the US Food and Drug Administration. Welcome back ...
"Vaccination continues to be the cornerstone of COVID-19 prevention," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research (CBER). "Given waning immunity of the ...
I think this year, we are feeling reassured in this regard,” Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research (CBER), told the Alliance for Regenerative Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback